Anna Walleback

Anna Walleback is a seasoned Clinical Project Manager with extensive experience in managing global clinical trials from planning through execution and closeout. Currently serving as a Sr. Clinical Project Manager at Ipsen since January 2024, Anna previously held similar roles at Albireo Pharma, Inc. and ICON plc, specializing in oncology and cell therapeutics. Anna's career at Bristol Myers Squibb spanned over a decade, where responsibilities included Nordic Project Manager and Clinical Site Manager, focusing on phase II-IV trials. Anna started in clinical research as a Clinical Site Monitor and progressed through roles at Got-A-Gene and Zyomyx Inc. Anna holds Master of Science degrees in Chemical Engineering from The Faculty of Engineering at Lund University and Santa Clara University.